Latest Drug Sales Projections News

Page 1 of 1

Neuren Confirms DAYBUE Sales Projection Could Boost Royalties to $700m by 2028

Neuren Pharmaceuticals has affirmed the material impact of Acadia’s projection that DAYBUE global net sales could reach approximately US$700 million by 2028, underpinning its royalty revenue outlook.

Ada Torres

19 Jan 2026

Browse the archive

Full archive

Sept 2026 Aug 2026 July 2026 June 2026 May 2026 Apr 2026 Mar 2026 Feb 2026

Top